ESAIY EISAI CO

$7.70

EISAI CO (ESAIY) has not yet scheduled its next earnings release.

Earnings Date
2nd Quarter, Sep 2026
TBD
· Market Hours
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About EISAI CO

Eisai Co. Ltd. engages in the research and development, manufacture, sale and import and export of pharmaceuticals principally in Japan. It offers Dayvigo, for the treatment of insomnia. The company also provides Methycobal for the treatment of peripheral neuropathy; Jyseleca, a janus kinase inhibitor; Goofice for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, treatment for dementia; and Chocola BB plus for the preparation vitamin B2. Eisai Co. Ltd. is based in Tokyo, Japan.

Charts powered in part by Lightweight Charts™ by TradingView.